Wall Street Experts
ver. ZuMIgo(08/25)
Neuren Pharmaceuticals Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 271
EBIT TTM (mln): 210
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
Rok finansowy |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
2 |
3 |
1 |
0 |
0 |
1 |
2 |
5 |
5 |
0 |
0 |
5 |
3 |
2 |
3 |
1 |
14 |
0 |
1 |
3 |
15 |
232 |
Przychód Δ r/r |
0.0% |
33.7% |
-50.6% |
-69.3% |
-59.7% |
445.9% |
140.9% |
120.0% |
-7.1% |
-100.0% |
0.0% |
inf% |
-38.9% |
-42.9% |
88.3% |
-80.0% |
2117.1% |
-96.5% |
44.8% |
345.9% |
355.2% |
1493.7% |
Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
0.0% |
-80.5% |
-241.7% |
-744.7% |
-323.0% |
-713.9% |
56.4% |
99.2% |
99.2% |
99.7% |
99.9% |
88.5% |
EBIT (mln) |
2 |
2 |
-8 |
-11 |
-12 |
-12 |
-9 |
0 |
-5 |
-5 |
-9 |
-9 |
-10 |
-16 |
-12 |
-6 |
6 |
-12 |
-10 |
-11 |
-2 |
199 |
EBIT Δ r/r |
0.0% |
45.5% |
-427.5% |
38.3% |
15.8% |
-0.7% |
-22.0% |
-101.4% |
-3904.6% |
-5.1% |
100.2% |
-0.3% |
2.9% |
60.2% |
-22.9% |
-49.5% |
-195.8% |
-299.0% |
-17.7% |
20.0% |
-86.0% |
-12583.0% |
EBIT (%) |
75.3% |
81.9% |
-543.3% |
-2447.2% |
-7040.7% |
-1280.7% |
-414.8% |
2.6% |
-107.3% |
0.0% |
0.0% |
-197.1% |
-331.7% |
-931.2% |
-381.5% |
-962.4% |
41.6% |
-2337.6% |
-1328.6% |
-357.5% |
-11.0% |
85.9% |
Koszty finansowe (mln) |
13 |
14 |
4 |
-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
EBITDA (mln) |
2 |
3 |
-6 |
-10 |
-11 |
-11 |
-8 |
1 |
-5 |
-4 |
-9 |
-9 |
-10 |
-15 |
-12 |
-6 |
6 |
-12 |
-10 |
-11 |
-2 |
199 |
EBITDA(%) |
100.0% |
100.0% |
-433.6% |
-2436.7% |
-6586.1% |
-1186.5% |
-365.5% |
12.7% |
-98.7% |
0.0% |
0.0% |
-188.2% |
-328.4% |
-925.9% |
-379.0% |
-950.2% |
42.1% |
-2336.8% |
-1327.8% |
-357.3% |
-10.9% |
85.9% |
Podatek (mln) |
-5 |
-6 |
-6 |
0 |
-2 |
0 |
0 |
0 |
-0 |
-0 |
-4 |
2 |
-0 |
1 |
-2 |
-1 |
-0 |
-0 |
-1 |
-3 |
-1 |
48 |
Zysk Netto (mln) |
-5 |
-6 |
-6 |
-8 |
-10 |
-12 |
-15 |
0 |
-5 |
-5 |
-5 |
-11 |
-8 |
-13 |
-12 |
3 |
3 |
-11 |
-9 |
-8 |
0 |
157 |
Zysk netto Δ r/r |
0.0% |
3.5% |
0.8% |
45.9% |
21.8% |
20.1% |
26.9% |
-100.6% |
-5014.9% |
-5.0% |
9.5% |
121.8% |
-26.6% |
61.5% |
-10.3% |
-127.4% |
-6.5% |
-452.0% |
-15.0% |
-15.2% |
-102.4% |
85270.1% |
Zysk netto (%) |
-257.3% |
-199.1% |
-406.8% |
-1933.7% |
-5848.5% |
-1287.1% |
-678.0% |
2.0% |
-105.3% |
0.0% |
0.0% |
-235.7% |
-283.1% |
-800.8% |
-381.4% |
521.1% |
22.0% |
-2185.1% |
-1282.1% |
-243.8% |
1.3% |
67.7% |
EPS |
-2.43 |
-2.51 |
-2.53 |
-1.51 |
-1.55 |
-1.64 |
-1.25 |
0.0073 |
-0.23 |
-0.12 |
-0.0868 |
-0.18 |
-0.11 |
-0.16 |
-0.14 |
0.0353 |
0.031 |
-0.11 |
-0.0859 |
-0.0662 |
0.0015 |
1.24 |
EPS (rozwodnione) |
-2.43 |
-2.51 |
-2.53 |
-1.51 |
-1.55 |
-1.64 |
-1.25 |
0.0073 |
-0.23 |
-0.12 |
-0.0868 |
-0.18 |
-0.11 |
-0.16 |
-0.14 |
0.0353 |
0.0308 |
-0.11 |
-0.0859 |
-0.0662 |
0.0014 |
1.2 |
Ilośc akcji (mln) |
2 |
2 |
2 |
5 |
7 |
7 |
12 |
15 |
21 |
38 |
59 |
63 |
78 |
84 |
85 |
92 |
99 |
100 |
107 |
118 |
126 |
127 |
Ważona ilośc akcji (mln) |
2 |
2 |
2 |
5 |
7 |
7 |
12 |
15 |
21 |
38 |
59 |
63 |
78 |
84 |
85 |
93 |
100 |
100 |
107 |
118 |
129 |
131 |
Waluta |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |